Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026)
Xeris Biopharma Holdings (XERS) recorded Accounts Payables of $9.34 million in Q2 2026, down 1.3% from $9.46 million a year earlier and down 18.6% from the prior quarter.
Xeris Biopharma Holdings (XERS) Accounts Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings reported Accounts Payables of $3.08 million, up 34.3% from FY2024.
- Annual Accounts Payables has a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- Across earlier years, Accounts Payables came in at $2.29 million in FY2024 (-80.2%), $11.57 million in FY2023 (+151.1%), $4.61 million in FY2022 (-48.4%) and $8.92 million in FY2021 (+186.3%).
- Quarterly Accounts Payables has ranged from $2.29 million in Q4 2024 to $12.08 million in Q3 2023 over the past five years.
- On a year-over-year basis, Accounts Payables rose in three of the last eight quarters, with growth averaging 4.4%.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 208.4% in Q3 2023, against a decline of 80.2% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.47 million (Q1 2026), $3.08 million (Q4 2025) and $6.53 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Xeris Biopharma Holdings | 1.66 Bn | 1.22 Bn | 79.59 Mn | 9.34 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.34 Mn |
| Mar 31, 2026 | 11.47 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 9.46 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 2.29 Mn |
| Sep 30, 2024 | 7.45 Mn |
| Jun 30, 2024 | 5.80 Mn |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | 11.57 Mn |
| Sep 30, 2023 | 12.08 Mn |
| Jun 30, 2023 | 11.62 Mn |
| Mar 31, 2023 | 11.98 Mn |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 6.63 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 4.29 Mn |
Xeris Biopharma Holdings Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=XERS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();